CatalystPit

MLYSMineralys Therapeutics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $25.13 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$2.22B
RECENT INSIDER TRADES
  • 2026-10-02 · Congleton Jon (Chief Executive Officer) · SELL
  • 2026-09-24 · Slingsby Brian Taylor (Director) · SELL
  • 2026-09-22 · Warren Eric (Chief Commercial Officer) · SELL
  • 2026-09-22 · Warren Eric (Chief Commercial Officer) · OTHER
  • 2026-09-17 · Karydas Daphne (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders237
Shares held105,771,635
Value$2.79B
Percent of shares outstanding119.64%
As of quarter end2026-06-30
RECENT NEWS
  • Mineralys Therapeutics, Inc. (MLYS) Presents at American Heart Association Hypertension Scientific Sessions 2026 - Slideshow
  • Mineralys Therapeutics presents lorundrostat hypertension trial data
  • Mineralys Therapeutics stock hits 52-week low at 22.23 USD
  • Mineralys Therapeutics to present lorundrostat data at ASN Kidney Week 2026
  • Mineralys to present lorundrostat data at AHA Hypertension conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS